vs

Side-by-side financial comparison of Bank7 Corp. (BSVN) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $24.1M, roughly 1.4× Bank7 Corp.). Bank7 Corp. runs the higher net margin — 44.7% vs -28.1%, a 72.8% gap on every dollar of revenue. On growth, Bank7 Corp. posted the faster year-over-year revenue change (-0.1% vs -18.9%). Bank7 Corp. produced more free cash flow last quarter ($41.4M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs 0.2%).

Bank7 Corp. is a U.S.-headquartered financial holding company that operates the full-service community bank Bank7. It provides a range of commercial and consumer banking products including deposit accounts, small business loans, commercial real estate financing, and personal lending solutions, with its primary market footprint covering Oklahoma, Texas, and Kansas, targeting small to medium-sized enterprises and retail customers.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

BSVN vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.4× larger
RXST
$32.6M
$24.1M
BSVN
Growing faster (revenue YoY)
BSVN
BSVN
+18.8% gap
BSVN
-0.1%
-18.9%
RXST
Higher net margin
BSVN
BSVN
72.8% more per $
BSVN
44.7%
-28.1%
RXST
More free cash flow
BSVN
BSVN
$43.6M more FCF
BSVN
$41.4M
$-2.3M
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
0.2%
BSVN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BSVN
BSVN
RXST
RXST
Revenue
$24.1M
$32.6M
Net Profit
$10.8M
$-9.2M
Gross Margin
77.5%
Operating Margin
58.7%
-34.8%
Net Margin
44.7%
-28.1%
Revenue YoY
-0.1%
-18.9%
Net Profit YoY
-2.9%
-54.1%
EPS (diluted)
$1.13
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BSVN
BSVN
RXST
RXST
Q4 25
$24.1M
$32.6M
Q3 25
$25.2M
$30.3M
Q2 25
$24.4M
$33.6M
Q1 25
$22.6M
$37.9M
Q4 24
$24.1M
$40.2M
Q3 24
$24.9M
$35.3M
Q2 24
$24.4M
$34.9M
Q1 24
$24.0M
$29.5M
Net Profit
BSVN
BSVN
RXST
RXST
Q4 25
$10.8M
$-9.2M
Q3 25
$10.8M
$-9.8M
Q2 25
$11.1M
$-11.8M
Q1 25
$10.3M
$-8.2M
Q4 24
$11.1M
$-5.9M
Q3 24
$11.8M
$-6.3M
Q2 24
$11.5M
$-6.1M
Q1 24
$11.3M
$-9.1M
Gross Margin
BSVN
BSVN
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
BSVN
BSVN
RXST
RXST
Q4 25
58.7%
-34.8%
Q3 25
56.2%
-40.1%
Q2 25
60.2%
-41.6%
Q1 25
60.7%
-28.2%
Q4 24
61.0%
-21.5%
Q3 24
62.2%
-26.1%
Q2 24
62.5%
-23.9%
Q1 24
62.0%
-36.2%
Net Margin
BSVN
BSVN
RXST
RXST
Q4 25
44.7%
-28.1%
Q3 25
43.0%
-32.4%
Q2 25
45.4%
-35.0%
Q1 25
45.7%
-21.6%
Q4 24
46.0%
-14.8%
Q3 24
47.3%
-17.9%
Q2 24
47.2%
-17.4%
Q1 24
47.0%
-30.8%
EPS (diluted)
BSVN
BSVN
RXST
RXST
Q4 25
$1.13
$-0.22
Q3 25
$1.13
$-0.24
Q2 25
$1.16
$-0.29
Q1 25
$1.08
$-0.20
Q4 24
$1.16
$-0.14
Q3 24
$1.24
$-0.16
Q2 24
$1.23
$-0.16
Q1 24
$1.21
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BSVN
BSVN
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$251.0M
$275.7M
Total Assets
$2.0B
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BSVN
BSVN
RXST
RXST
Q4 25
$228.1M
Q3 25
$227.5M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$237.1M
Q2 24
$233.3M
Q1 24
$125.4M
Stockholders' Equity
BSVN
BSVN
RXST
RXST
Q4 25
$251.0M
$275.7M
Q3 25
$241.7M
$276.0M
Q2 25
$231.9M
$278.0M
Q1 25
$221.7M
$279.3M
Q4 24
$213.2M
$281.2M
Q3 24
$204.2M
$277.3M
Q2 24
$190.8M
$275.2M
Q1 24
$180.4M
$163.9M
Total Assets
BSVN
BSVN
RXST
RXST
Q4 25
$2.0B
$311.8M
Q3 25
$1.9B
$308.5M
Q2 25
$1.8B
$309.0M
Q1 25
$1.8B
$313.0M
Q4 24
$1.7B
$318.6M
Q3 24
$1.7B
$310.5M
Q2 24
$1.7B
$305.5M
Q1 24
$1.8B
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BSVN
BSVN
RXST
RXST
Operating Cash FlowLast quarter
$46.1M
$-1.1M
Free Cash FlowOCF − Capex
$41.4M
$-2.3M
FCF MarginFCF / Revenue
171.7%
-6.9%
Capex IntensityCapex / Revenue
19.7%
3.5%
Cash ConversionOCF / Net Profit
4.28×
TTM Free Cash FlowTrailing 4 quarters
$74.8M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BSVN
BSVN
RXST
RXST
Q4 25
$46.1M
$-1.1M
Q3 25
$16.6M
$-1.2M
Q2 25
$9.4M
$-4.4M
Q1 25
$11.0M
$-8.8M
Q4 24
$55.0M
$-4.3M
Q3 24
$13.4M
$650.0K
Q2 24
$8.1M
$-4.0M
Q1 24
$20.4M
$-9.3M
Free Cash Flow
BSVN
BSVN
RXST
RXST
Q4 25
$41.4M
$-2.3M
Q3 25
$16.4M
$-1.8M
Q2 25
$8.8M
$-5.9M
Q1 25
$8.2M
$-9.4M
Q4 24
$50.8M
$-5.1M
Q3 24
$12.7M
$-453.0K
Q2 24
$6.5M
$-5.5M
Q1 24
$19.8M
$-11.3M
FCF Margin
BSVN
BSVN
RXST
RXST
Q4 25
171.7%
-6.9%
Q3 25
65.0%
-5.8%
Q2 25
36.1%
-17.6%
Q1 25
36.3%
-24.8%
Q4 24
210.6%
-12.7%
Q3 24
51.2%
-1.3%
Q2 24
26.8%
-15.9%
Q1 24
82.3%
-38.2%
Capex Intensity
BSVN
BSVN
RXST
RXST
Q4 25
19.7%
3.5%
Q3 25
0.8%
1.9%
Q2 25
2.6%
4.6%
Q1 25
12.4%
1.5%
Q4 24
17.4%
2.1%
Q3 24
2.5%
3.1%
Q2 24
6.6%
4.4%
Q1 24
2.8%
6.7%
Cash Conversion
BSVN
BSVN
RXST
RXST
Q4 25
4.28×
Q3 25
1.53×
Q2 25
0.85×
Q1 25
1.06×
Q4 24
4.96×
Q3 24
1.13×
Q2 24
0.71×
Q1 24
1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BSVN
BSVN

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons